Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort

Inclusion Criteria

• •Adult male and female subjects ≥18 years of age
• •Primary diagnosis with unilateral adult lower limb nonprogressive spasticity.
• •Subject able to take more than five steps with or without assistance.
• •Decision to treat the lower limb with aboBoNT-A by the care provider made prior to, and independently from, the decision to enroll the subject in the observational study as per country label.
• •Previously untreated with BoNT-A (i.e. naïve to BoNT-A), or previously treated with a BoNT-A (i.e. non-naïve to BoNT-A). For those who were previously treated with BoNTA, they should have responded to BoNT-A treatment and at least 12 weeks should have elapsed from prior injection.
• •Signed informed consent prior to participation in the study.